NCT06754852: A Study Assessing HMB-002 in Participants With Von Willebrand Disease
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 108 planned
- Started
- 6 Feb 2025
- Primary completion
- Jul 2027
- Arms
- Part B Multiple Dose Assessment
- Results
- None posted
- 1 Jan 2025: Trial registered
- 6 Feb 2025: Trial started